Tag: Liver Disease: Misc.

Normalization of alanine aminotransferase also seen with bulevirtide 2- or 10-mg

Improvements also seen in NASH resolution with pegozafermin 15 or 30 mg weekly, or 44 mg every two weeks

No difference seen in 28-day mortality or occurrence of serious adverse events; time to resolution of ACLF significantly faster

Predictors of abnormal liver function test include elderly onset of SSc, alcoholic drinking, and edematous skin

Absolute change in advanced liver disease highest in heavy alcohol use subgroups with and without MetS

Bariatric-metabolic surgery more effective than lifestyle modification plus best medical care

However, full vaccination associated with two-thirds lower risk for death with cirrhosis

Clinically meaningful treatment response occurs independently of weight loss

Among patients with obesity and nonalcoholic fatty liver disease, benefits seen for weight, insulin sensitivity, and liver enzymes

Rates of in-hospital mortality, failure to rescue decreased from a hospital volume threshold of >25 liver resections per year